X0306 4 2022-02-03 0 0001636651 Ovid Therapeutics Inc. OVID 0001256153 LEVIN JEREMY M C/O OVID THERAPEUTICS INC. 1460 BROADWAY, SUITE 15044 NEW YORK NY 10036 1 1 1 0 CEO Stock Option (Right to Buy) 2.72 2022-02-03 4 A 0 600000 0.00 A 2032-02-02 Common Stock 600000 600000 D 25% of the shares subject to the Stock Option will vest and become exercisable on February 3, 2023 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. /s/ Danielle Mann for Jeremy Levin by PoA 2022-02-04